Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 3/20 | 1.00 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.57 |
| ▸ | DAO | P14920 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2143573 | 1.00 | AHR (1.00) | AHRALOX5PTGS1PTGS2DAO | |
| SCHEMBL6460048 | 1.00 | AHR (1.00) | AHRALOX5PTGS1PTGS2DAO | |
| SCHEMBL260347 | 0.86 | AHR (0.74) | AHRALOX5PTGS1PTGS2DAO | |
| SCHEMBL1795502 | 0.86 | AHR (0.74) | AHRALOX5PTGS1PTGS2DAO | |
| SCHEMBL9679429 | 0.86 | AHR (0.74) | AHRALOX5PTGS1PTGS2DAO | |
| SCHEMBL699666 | 0.86 | AHR (0.74) | AHRALOX5PTGS1PTGS2DAO | |
| SCHEMBL9679426 | 0.86 | AHR (0.74) | AHRALOX5PTGS1PTGS2DAO | |
| SCHEMBL10458457 | 0.86 | AHR (0.74) | AHRALOX5PTGS1PTGS2DAO | |
| SCHEMBL20582895 | 0.86 | AHR (0.74) | AHRALOX5PTGS1PTGS2DAO | |
| SCHEMBL18002529 | 0.84 | AHR (0.72) | AHRALOX5PTGS1PTGS2DAO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 288 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025224460-A1 | METHODS FOR INDUCING NATURAL KILLER CELL DIFFERENTIATION | PLASTICELL LTD (GB) | 2025-10-30 | — | — | WO | claimed |
| WO-2025201290-A1 | METHOD FOR PREPARING PLATELETS | 苏州血霁生物科技有限公司 | 2025-10-02 | — | — | WO | claimed |
| CN-120033996-A | Low-cost high-voltage charge pump voltage stabilizing circuit and control method thereof | 上海帝迪集成电路设计有限公司 | 2025-05-23 | — | — | CN | claimed |
| WO-2025073655-A2 | USE OF ARTIFICIAL MARROW ORGANOID FOR GENERATING NK CELLS AND MYELOID CELLS | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-04-10 | — | — | WO | claimed |
| CN-119739238-A | Voltage stabilizing starting circuit without operational amplifier and applied to high voltage and voltage stabilizing starting method thereof | 上海帝迪集成电路设计有限公司 | 2025-04-01 | — | — | CN | claimed |
| WO-2025051967-A1 | METHOD OF PRODUCING PLASMACYTOID DENDRITIC CELLS | UNIKUM THERAPEUTICS APS (DK) | 2025-03-13 | — | — | WO | claimed |
| EP-4444870-A1 | METHODS AND COMPOSITIONS FOR GENERATING HUMAN ERYTHROID PROGENITOR CELLS | Trailhead Biosystems Inc. (US) | 2024-10-16 | — | — | EP | claimed |
| CN-118382694-A | Methods and compositions for generating human erythroid progenitors | 特雷尔赫德生物系统股份有限公司 | 2024-07-23 | — | — | CN | claimed |
| CN-117850204-A | Process image sharing across multiple programmable automation controllers | 施耐德电气工业公司 | 2024-04-09 | — | — | CN | claimed |
| EP-4345559-A1 | PROCESS IMAGE SHARING ACROSS MULTIPLE PROGRAMMABLE AUTOMATION CONTROLLERS | Schneider Electric Industries SAS (FR) | 2024-04-03 | — | — | EP | claimed |
| CN-114349822-B | Biological macromolecule modification method based on vinyl sulfonium salt | 深圳湾实验室坪山生物医药研发转化中心 | 2023-10-20 | — | — | CN | claimed |
| WO-2023107477-A1 | METHODS AND COMPOSITIONS FOR GENERATING HUMAN ERYTHROID PROGENITOR CELLS | TRAILHEAD BIOSYSTEMS INC. (US) | 2023-06-15 | — | — | WO | claimed |
| US-20230174938-A1 | METHODS AND COMPOSITIONS FOR GENERATING HUMAN ERYTHROID PROGENITOR CELLS | TRAILHEAD BIOSYSTEMS INC. | 2023-06-08 | — | — | US | claimed |
| US-20230032216-A1 | INTERLEUKIN-4-INDUCED GENE 1 (IL4I1) AND RESPECTIVE METABOLITES AS BIOMARKERS FOR CANCER | Deutsches Krebsforschungszentrum Stiftung des oeffentlichen Rechts Im Neuenheimer Feld 280 (DE) | 2023-02-02 | — | — | US | claimed |
| EP-4073273-A1 | INTERLEUKIN-4-INDUCED GENE 1 (IL4I1) AND RESPECTIVE METABOLITES AS BIOMARKERS FOR CANCER | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts (DE) | 2022-10-19 | — | — | EP | claimed |
| CN-114349822-A | Biomacromolecule modification method based on vinyl sulfonium salt | 深圳湾实验室坪山生物医药研发转化中心 | 2022-04-15 | — | — | CN | claimed |
| US-20260145318-A1 | Method for Operating a Device Networking System | LUCOMM TECHNOLOGIES, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| US-20260147346-A1 | Method for Operating a Semantic System | LUCOMM TECHNOLOGIES, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| WO-2004041758-A1 | NEW STILBENE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR LIGAND ANTAGONISTICS | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (I.N.S.E.R.M.) (FR) | 2004-05-21 | — | — | WO | disclosed |
| EP-1418164-A1 | New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonists | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) | 2004-05-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260145318-A1 | Method for Operating a Device Networking System | IL33, TRIM33, MICOS13 | AHR 1328/4885ALOX5 3877/4885PTGS1 1323/4885 |
| US-20260147346-A1 | Method for Operating a Semantic System | RAP1A, RIF1, TRRAP | AHR 3790/4885ALOX5 3427/4885PTGS1 3835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.